INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
77 hedge funds and large institutions have $15.8M invested in Infinity Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 26 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
-16
Holders Change %
-17.2%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
13
Reduced
26
Closed
29
Calls
$227K
Puts
$61K
Net Calls
+$166K
Net Calls Change
-$198K
Top Buyers
1 |
Millennium Management
New York
|
+$1.15M |
2 |
E
Ergoteles
New York
|
+$265K |
3 |
Citadel Advisors
Miami,
Florida
|
+$202K |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$70.5K |
5 |
Bank of America
Charlotte,
North Carolina
|
+$62.7K |
Top Sellers
1 |
BlackRock
New York
|
-$2.7M |
2 |
State Street
Boston,
Massachusetts
|
-$990K |
3 |
Nuveen Asset Management
Chicago,
Illinois
|
-$521K |
4 |
Northern Trust
Chicago,
Illinois
|
-$384K |
5 |
![]()
Marshall Wace
London,
United Kingdom
|
-$359K |